FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

Health & LifestyleNews
766

Listen to article (english)

Translate to Spanish or other 102 languages!

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Image for illustration purposes
On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Addyi was previously approved in 2015 for the treatment of HSDD in premenopausal women. Premenopause or “before” menopause refers to the reproductive time in a cisgender woman’s life when they have regular menstrual cycles.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/fda-approves-daily-pill-treat-low-libido-women-postmenopause-explainer?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-12-19&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Heart Association Highlights 2025’s Major Research Findings
Next article
From Patient to Hero: Isaac Garza Delivers 2,089 Smiles This Holiday Season

More Articles

Revised Stroke Guideline Extends Care Recommendations Across All Ages

Every minute counts when someone has a stroke, which occurs when blood flow to the brain is blocked. Without rapid treatment, brain cells begin dying within minutes, often leaving patients with permanent speech, movement or memory disabilities.

Supreme Court Prepares to Hear Landmark Birthright Citizenship Case

The Supreme Court of the United States is set to hear arguments on April 1, 2026, in a case that could reshape how citizenship is granted in the United States.

STHS Behavioral Highlights Stress Management in Upcoming Webinar, April 2nd 

Mega Doctor News Stress is a normal part of life. It’s a...

Texas AG Sues Dental Providers for Alleged Medicaid Fraud Scheme

Mega Doctor News AUSTIN – Attorney General Ken Paxton has filed suit against...
- Advertisement -